109 related articles for article (PubMed ID: 29752109)
1. The effect of the androstane lung cancer inhibitor content on the cell-selective toxicity of hydroxyapatite-chitosan-PLGA nanocomposites.
Ignjatović NL; Penov-Gaši KM; Ajduković JJ; Kojić VV; Marković SB; Uskoković DP
Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():371-377. PubMed ID: 29752109
[TBL] [Abstract][Full Text] [Related]
2. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-PLGA polymer blends as coatings for hydroxyapatite nanoparticles and their effect on antimicrobial properties, osteoconductivity and regeneration of osseous tissues.
Ignjatović N; Wu V; Ajduković Z; Mihajilov-Krstev T; Uskoković V; Uskoković D
Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():357-364. PubMed ID: 26706541
[TBL] [Abstract][Full Text] [Related]
4. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
Nie H; Wang CH
J Control Release; 2007 Jul; 120(1-2):111-21. PubMed ID: 17512077
[TBL] [Abstract][Full Text] [Related]
5. Inhalable microspheres embedding chitosan-coated PLGA nanoparticles for 2-methoxyestradiol.
Guo X; Zhang X; Ye L; Zhang Y; Ding R; Hao Y; Zhao Y; Zhang Z; Zhang Y
J Drug Target; 2014 Jun; 22(5):421-7. PubMed ID: 24417740
[TBL] [Abstract][Full Text] [Related]
6. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y
Int J Pharm; 2009 Dec; 382(1-2):198-204. PubMed ID: 19646519
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyapatite-chitosan biocomposites synthesized in the simulated body fluid and their drug loading studies.
Basargan T; Erdol-Aydin N; Nasun-Saygili G
J Mater Sci Mater Med; 2017 Oct; 28(11):180. PubMed ID: 28986683
[TBL] [Abstract][Full Text] [Related]
9. Investigating an organ-targeting platform based on hydroxyapatite nanoparticles using a novel in situ method of radioactive ¹²⁵Iodine labeling.
Ignjatović N; Vranješ Djurić S; Mitić Z; Janković D; Uskoković D
Mater Sci Eng C Mater Biol Appl; 2014 Oct; 43():439-46. PubMed ID: 25175234
[TBL] [Abstract][Full Text] [Related]
10. Poly(d,l-lactide-co-glycolide)-chitosan composite particles for the treatment of lung cancer.
Arya N; Katti DS
Int J Nanomedicine; 2015; 10():2997-3011. PubMed ID: 25945047
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of inhalable chitosan-modified poly (DL-lactic-co-glycolic acid) nanocomposite particles.
Yang M; Yamamoto H; Kurashima H; Takeuchi H; Yokoyama T; Tsujimoto H; Kawashima Y
Eur J Pharm Sci; 2012 Aug; 47(1):235-43. PubMed ID: 22683651
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of Fe
Atila Dinçer C; Yildiz N; Karakeçili A; Aydoğan N; Çalimli A
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1408-1414. PubMed ID: 27855499
[TBL] [Abstract][Full Text] [Related]
13. Ceria-containing uncoated and coated hydroxyapatite-based galantamine nanocomposites for formidable treatment of Alzheimer's disease in ovariectomized albino-rat model.
Wahba SM; Darwish AS; Kamal SM
Mater Sci Eng C Mater Biol Appl; 2016 Aug; 65():151-63. PubMed ID: 27157738
[TBL] [Abstract][Full Text] [Related]
14. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite.
Ho ML; Fu YC; Wang GJ; Chen HT; Chang JK; Tsai TH; Wang CK
J Control Release; 2008 Jun; 128(2):142-8. PubMed ID: 18436324
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
16. Chitosan Oligosaccharide Lactate Coated Hydroxyapatite Nanoparticles as a Vehicle for the Delivery of Steroid Drugs and the Targeting of Breast Cancer Cells.
Ignjatović NL; Sakač M; Kuzminac I; Kojić V; Marković S; Vasiljević-Radović D; Wu VM; Uskoković V; Uskoković DP
J Mater Chem B; 2018; 6(43):6957-6968. PubMed ID: 30931125
[TBL] [Abstract][Full Text] [Related]
17. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK
Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614
[TBL] [Abstract][Full Text] [Related]
18. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H
J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and characterization of tetrandrine-loaded PLGA nanocomposite particles by premix membrane emulsification coupled with spray-drying method].
Hu T; Zhu HX; Guo LW; Pan LM; Li B; Shi FY; Lu J
Yao Xue Xue Bao; 2014 Nov; 49(11):1607-13. PubMed ID: 25757290
[TBL] [Abstract][Full Text] [Related]
20. In vivo mineralization and osteogenesis of nanocomposite scaffold of poly(lactide-co-glycolide) and hydroxyapatite surface-grafted with poly(L-lactide).
Zhang P; Hong Z; Yu T; Chen X; Jing X
Biomaterials; 2009 Jan; 30(1):58-70. PubMed ID: 18838160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
